Baum MK, Campa A, Lai S, Lai H, Yang Z, Sales S, King K, Page B; International Conference on AIDS.
Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. ThPeB7323.
Florida International University, Miami, FL, United States
BACKGROUND: Zinc (Zn) deficiency is associated with immune abnormalities and increased susceptibility to infections. While Zn deficiency has been observed in various HIV+ populations, including those on HAART, its relevance in HIV disease is not understood. The objective of this study was to evaluate whether dietary Zn intake is related to Zn deficiency and mortality in HIV+ drug users. METHOD: Immunological, nutritional and clinical profiles of 118 HIV+ drug users were assessed every 6 months in Miami, Florida between 1994-98. HIV-related mortality was confirmed with data from the Medical Examiner. Zn intake was obtained by the Willet's food frequency questionnaire. The effect of dietary Zn intake on mortality was determined by a multivariate Cox proportional hazards model with dietary Zn and CD4 cell count as time-dependent covariates. RESULTS: HIV-related death occurred in 22 individuals during the course of the study. Mean intake of Zn (10.1 mg/day+/-5.5) was below the recommendations for healthy US population (RDA is 15 mg/day for men, 12 mg/day for women). Zn deficiency (plasma Zn=0.75microg/ml), was present in 56% (N=67), 7 of whom died during the follow-up period. Dietary Zn intake below the median of 9.34 mg/day dramatically increased risk for HIV related mortality (RH=36.9,p=0.03). When dietary Zn intake was treated as a continuous variable, a dose-response relationship between dietary Zn and mortality was found. The risk of dying from HIV-related disease decreased by 33% for every 1 mg/day increase in dietary Zn intake, and this relationship was independent of antiretroviral therapy, CD4 count at baseline and over time. CONCLUSIONS: Low dietary Zn intake is a strong independent predictor of mortality in HIV infected drug users. Clinical trial is ongoing to determine whether increasing dietary Zn intake will reduce HIV-associated mortality in this population. Support: NIDA, NIMH, FIC.>
Publication Types:
Keywords:
- Acquired Immunodeficiency Syndrome
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Female
- Florida
- HIV Infections
- HIV Seropositivity
- HIV-1
- Humans
- Male
- Nutritional Status
- Proportional Hazards Models
- Zinc
- mortality
Other ID:
UI: 102250981
From Meeting Abstracts